VTVT
NASDAQ
US
vTv Therapeutics Inc. - Class A Common Stock
$41,17
▲ +$0,64
(+1,58%)
Vol. 41K
3
Punteggio di Qualità
fail
Ricavi ✗
Utile netto ✗
>IPO ✗
Cap. mercato
$167.1M
ROE
-100,5%
Margine
-835,7%
D/E
0,46
Beta
0,56
52W
$13–$38
Consenso Wall Street
11 analisti · Apr 20263
Acquisto forte
7
Compra
1
Mantieni
0
Vendi
0
Vendita forte
90,9%
Rating Compra
Grafico dei Prezzi
Titoli simili
ARTV
Artiva Biotherapeutics Inc
$105.3M
RNAC
Cartesian Therapeutics Inc
$187.5M
WHWK
Whitehawk Therapeutics Inc
$114.1M
NKTX
Nkarta Inc
$131.4M
ABOS
Acumen Pharmaceuticals Inc
$127.8M
KALA
KALA BIO Inc
$12.2M
IMUX
Immunic Inc
$64.2M
TNYA
Tenaya Therapeutics Inc
$154.0M
HRTX
Heron Therapeutics Inc
$238.4M
UNCY
Unicycive Therapeutics Inc
$124.0M
Utili
Tasso di battuta: 50,0%
Prossimo report
Mag 13, 2026
Stima EPS: $-0,86
| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Mar 2026 | $-0,86 | — | — |
| Dic 2025 | $-1,11 | $-0,58 | +$0,53 |
| Set 2025 | $-1,00 | $-1,08 | $-0,08 |
| Giu 2025 | $-0,84 | $-0,92 | $-0,08 |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -206.4% | -144.9% | -206.4% | -206.4% | -100.5% | -100.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -835.7% | -835.7% | -835.7% | -835.7% | -835.7% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.46 | 0.46 |
| Current Ratio | 4.98 | 7.39 | 4.98 | 4.98 | 9.79 | 9.79 |
Rapporti chiave
ROA (TTM)
-47,8%
P/S (TTM)
164,33
P/B
3,4
EPS (TTM)
$-3,32
CF/Share
$-13,50
Crescita ricavi 3A
-36,7%
52W High
$38,46
52W Low
$13,15
$13,15
Intervallo 52 settimane
$38,46
Як VTVT виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка VTVT vs аналоги Biotechnology
P/E
—
▼
0%
sotto
peer
(18,8)
vs Peer
vs Settore
Sottovalutato
P/S
164,3
▲
1179%
sopra
peer
(12,9)
vs Peer
vs Settore
Più costoso
P/B
3,4
▲
39%
sopra
peer
(2,5)
vs Peer
vs Settore
Più costoso
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,0%)
vs Peer
vs Settore
Rendimento basso
Прибутковість VTVT vs аналоги Biotechnology
ROE
-100,5%
▼
49%
sotto
peer
(-67,3%)
vs Peer
vs Settore
Debole
Net margin
-835,7%
▼
191%
sotto
peer
(-286,8%)
vs Peer
vs Settore
Debole
Валова маржа
—
▼
0%
sotto
peer
(78,6%)
vs Peer
vs Settore
In linea
ROA
-47,8%
▼
2%
sotto
peer
(-46,7%)
vs Peer
vs Settore
In linea
Фінансове здоровʼя VTVT vs аналоги Biotechnology
D/E ratio
0,5
▼
0%
sotto
peer
(0,0)
vs Peer
vs Settore
In linea
Поточна ліквідність
9,8
▲
120%
sopra
peer
(4,4)
vs Peer
vs Settore
Liquidità forte
Beta
0,6
▼
42%
sotto
peer
(1,0)
vs Peer
vs Settore
Più volatile
Радар фундаменталів VTVT
VTVT
Mediana peer
Industria
VTVT прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio